CIS is a potent checkpoint in NK cell-mediated tumor immunity (vol 17, pg 816, 2016)

被引:0
|
作者
Delconte, Rebecca B.
Kolesnik, Tatiana B.
Dagley, Laura F.
Rautela, Jai
Shi, Wei
Putz, Eva M.
Stannard, Kimberley
Zhang, Jian-Guo
Teh, Charis
Firth, Matt
Ushiki, Takashi
Andoniou, Christopher E.
Degli-Esposti, Mariapia A.
Sharp, Phillip P.
Sanvitale, Caroline E.
Infusini, Giuseppe
Liau, Nicholas P. D.
Linossi, Edmond M.
Burns, Christopher J.
Carotta, Sebastian
Gray, Daniel H. D.
Seillet, Cyril
Hutchinson, Dana S.
Belz, Gabrielle T.
Webb, Andrew I.
Alexander, Warren S.
Li, Shawn S.
Bullock, Alex N.
Babon, Jeffrey J.
Smyth, Mark J.
Nicholson, Sandra E.
Huntington, Nicholas D.
机构
[1] The Walter and Eliza Hall Institute of Medical Research,Department of Medical Biology
[2] The University of Melbourne,Immunology and Virology Program, Centre for Ophthalmology and Visual Science, The University of Western Australia and Centre for Experimental Immunology
[3] Immunology in Cancer and Infection Laboratory QIMR Berghofer Medical Research Institute,Structural Genomics Consortium (SGC)
[4] Lions Eye Institute,Monash Institute of Pharmaceutical Sciences
[5] University of Oxford,Department of Biochemistry and the Siebens
[6] Monash University,Drake Medical Research Institute, Schulich School of Medicine and Dentistry
[7] University of Western Ontario,School of Medicine
[8] University of Queensland,undefined
关键词
D O I
10.1038/s41590-023-01714-8
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:371 / 372
页数:2
相关论文
共 50 条
  • [21] NK Cell-Mediated Processing Of Chlamydia psittaci Drives Potent Anti-Bacterial Th1 Immunity
    Radomski, Nadine
    Franzke, Kati
    Matthiesen, Svea
    Karger, Axel
    Knittler, Michael R.
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [22] Augmentation of NK cell-mediated cytotoxicity to tumor cells by inhibitory NK cell receptor blockers
    Tajima, K
    Matsumoto, N
    Ohmori, K
    Wada, H
    Ito, M
    Suzuki, K
    Yamamoto, K
    INTERNATIONAL IMMUNOLOGY, 2004, 16 (03) : 385 - 393
  • [24] Fasting reshapes tissue-specific niches to improve NK cell-mediated anti-tumor immunity
    Delconte, Rebecca B.
    Owyong, Mark
    Santosa, Endi K.
    Srpan, Katja
    Sheppard, Sam
    McGuire, Tomi J.
    Abbasi, Aamna
    Diaz-Salazar, Carlos
    Chun, Jerold
    Rogatsky, Inez
    Hsu, Katharine C.
    Jordan, Stefan
    Merad, Miriam
    Sun, Joseph C.
    IMMUNITY, 2024, 57 (08)
  • [25] Type I IFN signaling on dendritic cells is required for NK cell-mediated anti-tumor immunity
    Karimi, Khalil
    Karimi, Yalda
    Chan, Jeffrey
    Boudreau, Jeanette E.
    Basset, Jennifer
    Chew, Marianne V.
    Reid, Sarah
    Bramson, Jonathan L.
    Wan, Yonghong
    Ashkar, Ali A.
    INNATE IMMUNITY, 2015, 21 (06) : 626 - 634
  • [26] IN-VIVO METHODS FOR ASSESSMENT OF CELL-MEDIATED TUMOR IMMUNITY
    BARTLETT, GL
    NATIONAL CANCER INSTITUTE MONOGRAPHS, 1972, (M35): : 27 - 32
  • [27] Antigen Localization Controls T Cell-Mediated Tumor Immunity
    Zeelenberg, Ingrid S.
    van Maren, Wendy W. C.
    Boissonnas, Alexandre
    Van Hout-Kuijer, Maaike A.
    Den Brok, Martijn H. M. G. M.
    Wagenaars, Jori A. L.
    van der Schaaf, Alie
    Jansen, Eric J. R.
    Amigorena, Sebastian
    Thery, Clotilde
    Figdor, Carl G.
    Adema, Gosse J.
    JOURNAL OF IMMUNOLOGY, 2011, 187 (03): : 1281 - 1288
  • [28] IN-VITRO METHODS FOR ASSESSMENT OF CELL-MEDIATED TUMOR IMMUNITY
    NORDIN, AA
    NATIONAL CANCER INSTITUTE MONOGRAPHS, 1972, (M35): : 21 - 26
  • [29] SUPPRESSION OF CELL-MEDIATED TUMOR IMMUNITY BY CORYNEBACTERIUM-PARVUM
    KIRCHNER, H
    GLASER, M
    HERBERMAN, RB
    NATURE, 1975, 257 (5525) : 396 - 398
  • [30] INHIBITION OF HUMAN CELL-MEDIATED TUMOR IMMUNITY BY A SERUM FACTOR
    GOLDBERG, C
    DEINHARD.F
    JOHNSON, T
    JOURNAL OF THE RETICULOENDOTHELIAL SOCIETY, 1972, 11 (04): : 406 - &